QP 24 - Radiation and Cancer Biology 7: Tumor Immune Interactions

Presentations

• 10:30am - 11:30am PT

  Radiation and Cancer Biology 7: Tumor Immune Interactions

  Speaker: Gregory Gan, MD, PhD - KUMC, Kansas city
• 10:30am - 11:30am PT

  Radiation and Cancer Biology 7: Tumor Immune Interactions

  Speaker: Stephanie Markovina, MD, PhD - Washington University, St. Louis
• 10:35am - 10:40am PT

  ADAR1 Expression in CD8⁺ T Cells Modulates Radiotherapy Response and Prognosis in Non-Small Cell Lung Cancer via Disrupting Mitochondrial Function

  Speaker: Chen Tian, PhD - Department of Radiation Oncology and Shandong Provincial Key Laboratory of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical, Jinan
• 10:40am - 10:45am PT

  Tumor Immune Microenvironment Modulation by Single-Fraction vs. Multifraction SBRT in an Orthotopic NSCLC Mouse Model

  Speaker: Lea Bouchard, MD, MS - University of Sherbrooke, Sherbrooke
• 10:45am - 10:50am PT

  hnRNPA1 Impedes the Anti-Tumor Immune Response Effect via Competitively Inhibiting TRIM21-Mediated Ubiquitination and Degradation of CD155

  Speaker: Lu Zhang, - College of Medicine, Chongqing University, Chongqing
• 10:55am - 11:00am PT

  Focal Adhesion Kinase Targeting Enhances Anti-Tumor Immunity Following Conventionally Fractionated Radiation

  Speaker: Brian Leibowitz, PhD - University of Pittsburgh, Pittsburgh
• 11:00am - 11:05am PT

  Quantifying pan-cancer immune temperature to predict patient-specific radiation response and outcome

  Speaker: Awino Maureiq Ojwang, PhD - MD Anderson Cancer Center, Houston
• 10:50am - 10:55am PT

  Conventional Fractionated Elective Nodal Irradiation Preserves Early Antitumor Immunity and Efficacy Compared to Hypofractionated Protocols

  Speaker: Genki Sato, MD - Kyoto University Graduate School of Medicine, Kyoto